Pouncing on the chemokine receptor Chimera.
Mascolini
M
M
D016915:AIDS Vaccines; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D065100:CCR5 Receptor Antagonists; D018925:Chemokines / Q000502:physiology; D002648:Child; D004359:Drug Therapy, Combination; D020022:Genetic Predisposition to Disease; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D015497:HIV-1 / Q000502:physiology*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage / Q000627:therapeutic use; D008213:Lymphocyte Activation; D008212:Lymphocyte Depletion; D008251:Macaca; D008264:Macrophages / Q000378:metabolism / Q000821:virology; D009154:Mutation; D019713:Receptors, CCR5 / Q000502:physiology*; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors / Q000502:physiology*; D019438:Ritonavir / Q000008:administration & dosage / Q000627:therapeutic use; D015302:Simian Immunodeficiency Virus / Q000502:physiology; D013601:T-Lymphocytes / Q000378:metabolism / Q000821:virology; D014779:Virus Replication
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists; D018925:Chemokines; D017320:HIV Protease Inhibitors; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D019469:Indinavir; D019438:Ritonavir